114 related articles for article (PubMed ID: 27079458)
41. Cytomegalovirus pneumonia in immunocompetent host: case report and literature review.
Grilli E; Galati V; Bordi L; Taglietti F; Petrosillo N
J Clin Virol; 2012 Dec; 55(4):356-9. PubMed ID: 22975082
[TBL] [Abstract][Full Text] [Related]
42. Editorial commentary: Use of valganciclovir for prevention and treatment of cytomegalovirus disease.
Snydman DR
Clin Infect Dis; 2008 Jan; 46(1):28-9. PubMed ID: 18171209
[No Abstract] [Full Text] [Related]
43. Acyclovir in immunocompromised patients with cytomegalovirus disease. A controlled trial at one institution.
Balfour HH; Bean B; Mitchell CD; Sachs GW; Boen JR; Edelman CK
Am J Med; 1982 Jul; 73(1A):241-8. PubMed ID: 6285715
[No Abstract] [Full Text] [Related]
44. [Cytomegalovirus infection in adults. Must it be treated?].
Castón JJ; Torre-Cisneros J
Med Clin (Barc); 2016 Oct; 147(8):345-347. PubMed ID: 27450161
[No Abstract] [Full Text] [Related]
45. Clinical aspects of cytomegalovirus antiviral resistance in solid organ transplant recipients.
Le Page AK; Jager MM; Iwasenko JM; Scott GM; Alain S; Rawlinson WD
Clin Infect Dis; 2013 Apr; 56(7):1018-29. PubMed ID: 23243176
[TBL] [Abstract][Full Text] [Related]
46. Treatment and prevention of cytomegalovirus pneumonia after bone marrow transplantation: where do we stand?
Forman SJ; Zaia JA
Blood; 1994 May; 83(9):2392-8. PubMed ID: 8167329
[No Abstract] [Full Text] [Related]
47. Cytomegalovirus: Unusual Etiology of Lung Pseudotumor.
Farooq MA; Bhardwaj H; Jones KR
Am J Med Sci; 2015 Sep; 350(3):237-8. PubMed ID: 26114358
[No Abstract] [Full Text] [Related]
48. Severe cytomegalovirus (CMV) community-acquired pneumonia (CAP) precipitating a systemic lupus erythematosus (SLE) flare.
Cunha BA; Gouzhva O; Nausheen S
Heart Lung; 2009; 38(3):249-52. PubMed ID: 19486795
[TBL] [Abstract][Full Text] [Related]
49. Cidofovir as primary pre-emptive therapy for post-transplant cytomegalovirus infections.
Chakrabarti S; Collingham KE; Osman H; Fegan CD; Milligan DW
Bone Marrow Transplant; 2001 Nov; 28(9):879-81. PubMed ID: 11781649
[TBL] [Abstract][Full Text] [Related]
50. GESITRA-SEIMC/REIPI recommendations for the management of cytomegalovirus infection in solid-organ transplant patients.
de la Torre-Cisneros J; Fariñas MC; Castón JJ; Aguado JM; Cantisán S; Carratalá J; Cervera C; Cisneros JM; Cordero E; Crespo-Leiro MG; Fortún J; Frauca E; Gavaldá J; Gil-Vernet S; Gurguí M; Len O; Lumbreras C; Marcos MÁ; Martín-Dávila P; Monforte V; Montejo M; Moreno A; Muñoz P; Navarro D; Pahissa A; Pérez JL; Rodriguez-Bernot A; Rumbao J; San Juan R; Santos F; Varo E; Zurbano F;
Enferm Infecc Microbiol Clin; 2011 Dec; 29(10):735-58. PubMed ID: 21925772
[TBL] [Abstract][Full Text] [Related]
51. Intragraft cytomegalovirus infection: a randomized trial of valacyclovir prophylaxis versus pre-emptive therapy in renal transplant recipients.
Reischig T; Nemcová J; Vanecek T; Jindra P; Hes O; Bouda M; Treska V
Antivir Ther; 2010; 15(1):23-30. PubMed ID: 20167988
[TBL] [Abstract][Full Text] [Related]
52. [A case of successful treatment with ganciclovir for cytomegalovirus pneumonia after pulmonary lobectomy].
Inaba H; Ohta S; Nishimura T; Takamochi K; Ishida I; Etoh T; Honda A; Nakajima H; Muro H; Nagashima Y
Kyobu Geka; 1997 Nov; 50(12):1004-8. PubMed ID: 9388344
[TBL] [Abstract][Full Text] [Related]
53. Reduced Mortality of Cytomegalovirus Pneumonia After Hematopoietic Cell Transplantation Due to Antiviral Therapy and Changes in Transplantation Practices.
Erard V; Guthrie KA; Seo S; Smith J; Huang M; Chien J; Flowers ME; Corey L; Boeckh M
Clin Infect Dis; 2015 Jul; 61(1):31-9. PubMed ID: 25778751
[TBL] [Abstract][Full Text] [Related]
54. Failure of pre-emptive treatment of cytomegalovirus infections and antiviral resistance in stem cell transplant recipients.
van der Beek MT; Marijt EW; Vossen AC; van der Blij-de Brouwer CS; Wolterbeek R; Halkes CJ; Claas EC; Kroes AC
Antivir Ther; 2012; 17(1):45-51. PubMed ID: 22267468
[TBL] [Abstract][Full Text] [Related]
55. Treatment of cytomegalovirus pneumonia after bone marrow transplantation with cytomegalovirus immunoglobulin combined with ganciclovir.
Verdonck LF; de Gast GC; Dekker AW; de Weger RA; Schuurman HJ; Rozenberg-Arska M
Bone Marrow Transplant; 1989 Mar; 4(2):187-9. PubMed ID: 2539877
[TBL] [Abstract][Full Text] [Related]
56. Antiviral chemotherapy for pneumonia in children.
Yamauchi T
Semin Respir Infect; 1987 Sep; 2(3):184-7. PubMed ID: 3685673
[TBL] [Abstract][Full Text] [Related]
57. Can leflunomide play a role in cytomegalovirus disease prophylaxis besides its antirheumatic effects?
Lu CH; Tsai JH; Wu MZ; Yu CL; Hsieh SC
Antivir Ther; 2015; 20(1):93-6. PubMed ID: 24831792
[TBL] [Abstract][Full Text] [Related]
58. Acyclovir in treatment of cytomegalovirus pneumonia after cardiac transplantation.
Ashraf MH; Campalani GC; Qureshi SA; Froud DJ; Yacoub MH
Lancet; 1982 Jan; 1(8264):173-4. PubMed ID: 6119553
[No Abstract] [Full Text] [Related]
59. Case study: rapid emergence of a cytomegalovirus UL97 mutant in a heart-transplant recipient on pre-emptive ganciclovir therapy.
Gilbert C; LeBlanc MH; Boivin G
Herpes; 2001 Nov; 8(3):80-2. PubMed ID: 11867025
[TBL] [Abstract][Full Text] [Related]
60. [Active HCMV infection behind acute inflammatory bowel disease. Causal role or epiphenomenon still to be proved].
Dzabic M; Rahbar A
Lakartidningen; 2008 May 7-13; 105(19):1378-81. PubMed ID: 18574974
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
